Quick Answer
USANA HEALTH SCIENCES INC reported Operating Income Loss of $37.43 million for the year ending 2025.
- USANA HEALTH SCIENCES INC showed a decrease of -43.6% in Operating Income Loss from 2024 to 2025.
- This data is from USANA HEALTH SCIENCES INC's annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), USANA HEALTH SCIENCES INC's Operating Income Loss has declined by 26.3%.
- Historical annual values: Fiscal year 2025: $37.43 million | Fiscal year 2024: $66.32 million | Fiscal year 2023: $93.07 million | Fiscal year 2022: $107.61 million | Fiscal year 2021: $170.19 million | Fiscal year 2020: $176.49 million | Fiscal year 2019: $146.19 million | Fiscal year 2018: $188.35 million | Fiscal year 2017: $132.50 million | Fiscal year 2016: $138.62 million | Fiscal year 2015: $141.66 million | Fiscal year 2014: $116.10 million | Fiscal year 2013: $116.71 million | Fiscal year 2012: $98.18 million | Fiscal year 2011: $77.26 million | Fiscal year 2010: $68.22 million | Fiscal year 2009: $50.79 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: